Investments
As part of its ONE Ford initiative, Ford Motor Company has chosen North Plains Systems Inc.'s TeleScope as its global digital asset management solution to streamline the creation and distribution of marketing materials. The new system will help Ford manage, share, and distribute digital media files among its
Investments
Merchants Information Solutions, Inc. has released a whitepaper addressing the growing concern of small business ID theft and fraud. According to Russ Johnson, President and CEO of Merchants, the whitepaper was created in response to the increasing trend of small business ID theft and data breach events in 2009. The
Investments
Seven Summits Research has released PriceWatch Alerts for five stocks: FCX, TXN, BP, ADP, and UNM, in response to uncertain market conditions. These alerts provide concise detailed strategies for each stock and include position protection tactics designed to mitigate potential losses. According to Reid Stratton, Senior Analyst at Seven Summits,
Investments
Thales has announced that its payShield Cardholder Authentication for nShield is now available for its nShield Connect and nShield PCI Express hardware security modules (HSMs). This move aims to protect credit card information and assist with regulatory compliance, such as PCI. The solution is widely deployed in web-based applications for
Investments
The sixth annual Global Sourcing Summit in China revealed plans for a massive 5.7-square kilometer software city, scheduled to be built over the coming years. The city, located in the Xi'an software park, aims to host over 200,000 global IT entrepreneurs, offering a unique opportunity for
Investments
Hara, a leading provider of environmental and energy management software, has been recognized as an Emerging Leader in the Enterprise Carbon Accounting (ECA) software market by Groom Energy Solutions. This distinction is featured in the report, "Enterprise Carbon Accounting: An Analysis of Corporate-Level Greenhouse Gas (GHG) Emission Reporting and
Investments
QuadraMed Corporation, a leading provider of healthcare information technologies and services, has partnered with e-MDs to provide an ambulatory electronic health record (EHR) solution to University Medical Center at Princeton's affiliated physician practices. This innovative EHR solution will enable clinicians to access complete patient information across the continuum
Investments
Eclipsys Corporation, The Outcomes Company, announced that Athens Regional Medical Center (Athens Regional), a 375-bed regional referral center located in Athens, GA, has selected Eclipsys PeakPractice electronic medical record (EMR)/practice management (PM) solution. As a current user of Eclipsys' integrated clinical system, Sunrise Enterprise, Athens Regional will use
Investments
Marvell, a leading provider of integrated silicon solutions, will showcase its latest innovations at the Consumer Electronics Show (CES), furthering its mission to pioneer the always-on lifestyle. The company's complete product platforms for always-on, always-connected devices will enable consumers to experience rich live digital content on-demand, anytime, anywhere,
Investments
Mutual Funds Against Cancer, a leading advocate in the fight against cancer within the mutual fund and financial services industries, has announced Interactive Data Corporation as its Foundation Partner for 2010. This marks the third consecutive year that Interactive Data serves as MFAC's Foundation Partner, further solidifying their
Drugs
Continuous treatment with the oral drug REVLIMID following a stem cell transplant significantly prolongs remission in patients with multiple myeloma, according to a new study sponsored by the National Cancer Institute. This approach allows patients to manage their cancer while living an active lifestyle, as demonstrated by Elijah Alexander, founder
Drugs
Cancer patients may benefit from a novel carbohydrate polymer developed by Pro-Pharmaceuticals, Inc. DAVANAT targets Galectin receptors over-expressed on cancer cells, potentially increasing survival rates and reducing side effects. Preliminary results from clinical trials suggest that combining DAVANAT with chemotherapy or biologics can extend median survival and decrease adverse reactions.
